JF
EDIT icon

Jump Financial’s Editas Medicine EDIT Stock Holding History

Jump Financial’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-28,159
Closed -$285K – 1988
2023
Q4 		$285K Buy
28,159
+8,329
+42% +$73.1K 0.01% 1368
2023
Q3 		$155K Buy
19,830
+5,866
+42% +$50.3K 0.01% 1601
2023
Q2 		$115K Sell
13,964
-129,687
-90% -$1.13M ﹤0.01% 1636
2023
Q1 		$1.04M Buy
143,651
+124,546
+652% +$1.11M 0.04% 581
2022
Q4 		$169K Sell
19,105
-47,928
-71% -$526K 0.01% 1330
2022
Q3 		$821K Sell
67,033
-1,851
-3% -$28.8K 0.03% 689
2022
Q2 		$815K Buy
68,884
+13,844
+25% +$185K 0.03% 661
2022
Q1 		$1.05M Buy
55,040
+45,616
+484% +$848K 0.04% 507
2021
Q4 		$250K Buy
+9,424
New +$324K 0.02% 990
2021
Q2 		– Sell
-51,700
Closed -$2.17M – 1157
2021
Q1 		$2.17M Buy
+51,700
New +$2.95M 0.2% 67

Other funds holding EDIT

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Jump Financial's EDIT Position: Q1 2024 in Review

Jump Financial sold out of Editas Medicine (EDIT) in Q1 2024, closing a stake of 28,159 shares — an estimated $285K sold.

Jump Financial first reported a position in EDIT in Q1 2021 and held it in 10 quarters. The position peaked at $2.17M in Q1 2021. 225 funds tracked by Wall St. Rank hold EDIT as of Q1 2024.

  • Jump Financial reported no remaining Editas Medicine position as of Q1 2024 after selling out during the quarter.
  • Jump Financial sold 28,159 Editas Medicine shares in Q1 2024, an estimated $285K.
  • Jump Financial first reported a position in Editas Medicine in Q1 2021 and held it in 10 quarters.
  • Jump Financial's Editas Medicine position peaked at $2.17M in Q1 2021.
  • 225 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2024.

Based on Jump Financial's 13F filing for Q1 2024, filed 13 May 2024.